Pharmaceutical - Pharmaceutical, Global

Filter

Current filters:

PharmaceuticalGlobal

Popular Filters

1 to 25 of 290 results

30% increase in R&D projects for neglected diseases in 2014; report

24-02-2015

Trade group the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) has released…

GlobalPharmaceuticalResearchTropical diseases

Moderate growth forecast for colorectal cancer drug market

22-01-2015

The value of the colorectal cancer (CRC) therapeutics market will increase moderately, from $8.3 billion…

AvastinBayerBristol-Myers SquibbErbituxGlobalMarkets & MarketingMerck KGaAOncologyPharmaceuticalRocheStivarga

UCB signs up to $480 million global collaboration with Neuropore on PD

18-01-2015

Neuropore Therapies, a wholly-owned US subsidiary of Austria’s Ever Neuro Pharma, has entered into…

Ever Neuro PharmaGlobalLicensingNeurologicalNeuropore TherapiesNPT200-11PharmaceuticalResearchUCB

Baby boomers and BRICS will boost industry in 2015, report predicts

Baby boomers and BRICS will boost industry in 2015, report predicts

15-01-2015

The biggest trends in the health care industry in 2014 are expected to develop further in 2015, according…

GlobalHealthcareInternational relationsMarketResearch.comPharmaceutical

EXPERT VIEW: Who are you hiring and acquiring? People risks in pharma

EXPERT VIEW: Who are you hiring and acquiring? People risks in pharma

15-01-2015

The pharmaceutical industry faces a number of unique challenges when recruiting staff. Unlike in many…

BoardroomGlobalHireRightPharmaceuticalPharmacology

2014 a memorable year for M&A activity in pharma sector

2014 a memorable year for M&A activity in pharma sector

15-01-2015

2014 was a busy year for merger and acquisition activity in the pharmaceutical industry, but will be…

GlobalMergers & AcquisitionsPfizerPharmaceuticalShire

Health care and pharma execs optimistic about business conditions in 2015: Economist report

Health care and pharma execs optimistic about business conditions in 2015: Economist report

14-01-2015

More than half of pharma and healt care executives expect business conditions for their company to improve…

GlobalMarkets & MarketingPharmaceuticalPricingProductionResearch

Bristol-Myers Squibb enters global research accord with Calibr

06-01-2015

US pharma major Bristol-Myer Squibb has signed a worldwide research collaboration with the California…

Bristol-Myers SquibbGlobalLicensingPharmaceuticalResearchRespiratory and Pulmonary

Plasma fractionation market forecasts to 2019

06-01-2015

The global plasma fractionation market is witnessing continuous growth. The rise in aging population…

Baxter InternationalBio Product LaboratoryBiotestCSL LtdGlobalGrifolsHematologyKedrionLFB BiotechnologiesMarkets & MarketingOctapharmaPharmaceuticalSanquin

EXPERT VIEW: Strengthening market access through insight-driven real-world evidence

EXPERT VIEW: Strengthening market access through insight-driven real-world evidence

05-01-2015

Growing demand for access to health care alongside advances in science and technology has led to heightened…

EnbrelGlobalPharmaceuticalRegulationSenior Consulting

Top five health care trends of 2014 identified by Kalorama

Top five health care trends of 2014 identified by Kalorama

30-12-2014

Kalorama Information has identified its "Top Five Trends in Healthcare in 2014." The healthcare market…

GlobalHealthcareMergers & AcquisitionsPharmaceuticalProduction

Top 30 Pharmas spent $112 billion on R&D in 2013; report

Top 30 Pharmas spent $112 billion on R&D in 2013; report

17-12-2014

The world’s leading 30 pharmaceutical companies spent a combined $112 billion on research and development…

FinancialGlobalGlobalDataJohnson & JohnsonNovartisPfizerPharmaceuticalPharmaceutical sciencesResearch

Big savings on HIV drugs via pooled procurement expected by Global Fund

Big savings on HIV drugs via pooled procurement expected by Global Fund

12-12-2014

The Global Fund to Fight AIDS, Tuberculosis and Malaria is putting into place a new agreement for purchasing…

Anti-viralsFinancialGlobalHealthcarePharmaceuticalPricing

2015 will see blockbuster drug launches and more big M&A deals, report predicts

2015 will see blockbuster drug launches and more big M&A deals, report predicts

11-12-2014

Innovation will continue to drive the pharma and biotech sectors in 2015, according to EP Vantage’s…

GlobalHarvoniLCZ696Markets & MarketingPharmaceutical

Patent cliff means pharma will lose $65 billion by 2019, says report

Patent cliff means pharma will lose $65 billion by 2019, says report

11-12-2014

Pharmaceutical companies will suffer an estimated $65 billion drop in sales by 2019 due to the patent…

AbilifyAstraZenecaEli LillyGlobalMarkets & MarketingNeurologicalOtsukaPatentsPharmaceuticalSeroquelZyprexa

World Health Organization releases new guidance on cervical cancer prevention

World Health Organization releases new guidance on cervical cancer prevention

03-12-2014

The World Health Organization has issued new guidance to prevent and control cervical cancer.

GlobalOncologyPharmaceuticalResearchSocial IssuesWorld Health Organization

WHO's calls for more thorough clinical trial result disclosure welcomed by Germany's IQWiG

WHO's calls for more thorough clinical trial result disclosure welcomed by Germany's IQWiG

27-11-2014

The World Health Organization (WHO) has made an official statement on the disclosure of clinical trial…

GlobalHealthPharmaceuticalRegulationResearchWorld Health Organization

Global oncology market to hit $109 billion in 2020

Global oncology market to hit $109 billion in 2020

26-11-2014

Cancer, with a death toll exceeding that of AIDS (acquired immune deficiency syndrome), tuberculosis…

AvastinCelgene Corp.GlobalMarkets & MarketingMergers & AcquisitionsNovartisOncologyPharmaceuticalResearchRevlimidRoche

Acute myeloid leukemia treatment market will grow to $878.6 million by 2020

Acute myeloid leukemia treatment market will grow to $878.6 million by 2020

25-11-2014

The global acute myeloid leukemia therapeutics market is predicted to increase from $632.6 million in…

GlobalMarkets & MarketingmidostaurinOncologyPharmaceuticalquizartinib

Cost of bringing new drug to market now around $2.6 billion, says Tufts CSDD

19-11-2014

Developing a new prescription medicine that gains marketing approval, a process often lasting longer…

FinancialGlobalPharmaceuticalResearch

Pharma companies can still improve access to medicines, report shows

Pharma companies can still improve access to medicines, report shows

17-11-2014

Top pharma companies are doing more to improve access to medicine in developing countries over the last…

GlaxoSmithKlineGlobalMarkets & MarketingNovo NordiskPharmaceuticalSanofi

Internationally health economic evaluations are a fixed component of reimbursement decisions, says IQWiG

17-11-2014

Internationally health economic evaluations (HEEs) form a legally regulated fixed component in health-care…

GermanyGlobalPharmaceuticalPricingRegulation

Ulcerative colitis market to hit $4.2 billion by 2023

Ulcerative colitis market to hit $4.2 billion by 2023

13-11-2014

The ulcerative colitis market is set to grow from $2.7 billion in 2013 to $4.2 billion in 2023 in the…

Decision Resources GroupEntyvioGastro-intestinalsGlobalMarkets & MarketingPharmaceuticalRemicadeResearchXeljanz

GSK COPD survey shows many sufferers underestimate the severity of their condition

GSK COPD survey shows many sufferers underestimate the severity of their condition

12-11-2014

UK pharma major GlaxoSmithKline has conducted a global survey of people living with chronic obstructive…

GlobalGSKPharmaceuticalResearchRespiratory and PulmonaryUnited States

1 to 25 of 290 results

COMPANY SPOTLIGHT

Menarini

Back to top